When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study
Journal of Infection and Public Health · 2023
DOI: 10.1016/j.jiph.2023.06.011 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Infection and Public Health, 2023. Verfasst von Khalid Al Sulaiman und 19 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; College of Pharmacy, King Saud bin Abdulaziz University for Health…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Princess Nourah Bint Abdulrahman University, King Abdullah International Medical Research Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical R…
- Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
- Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia; Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
- Pharmaceutical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.
- Pharmaceutical Care Services, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
- Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Förderung
- Princess Nourah Bint Abdulrahman University
- King Abdullah International Medical Research Center
Zitieren
APA
Al Sulaiman, K., Aljuhani, O., Korayem, G. B., Altebainawi, A. F., AlFaifi, M., Nahari, M., Almagthali, A., Thabit, A. K., Alhajaji, R., Alharbi, R., Kahtani, K., Alenazi, A. A., Alharbi, A., Alghwainm, M. M., Alotaibi, S. M., Alghamdi, Y. S., Alotaibi, S., Alonazi, S. H., Almutairi, J. M., & Vishwakarma, R. (2023). When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2023.06.011
Vancouver
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, AlFaifi M, Nahari M, et al. When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study. Journal of Infection and Public Health. 2023. doi:10.1016/j.jiph.2023.06.011
BibTeX
@article{AlSulaiman2023,
author = {Al Sulaiman, Khalid and Aljuhani, Ohoud and Korayem, Ghazwa B and Altebainawi, Ali F and AlFaifi, Mashael and Nahari, Majed and Almagthali, Alaa and Thabit, Abrar K and Alhajaji, Raghad and Alharbi, Reham and Kahtani, Khawla and Alenazi, Abeer A and Alharbi, Aisha and Alghwainm, Munirah M and Alotaibi, Sara M and Alghamdi, Yazeed S and Alotaibi, Samar and Alonazi, Shaden H and Almutairi, Jumanah M and Vishwakarma, Ramesh},
title = {When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study},
journal = {Journal of Infection and Public Health},
year = {2023},
doi = {10.1016/j.jiph.2023.06.011}
}
EUVIMED